Immunity Defense Blend

LL-37/Thymosin A-1 immune support.

The Immunity Defense Blend combines LL-37 and Thymosin Alpha-1 for a comprehensive immune support protocol.

How it works

LL-37 provides direct antimicrobial action while Thymosin A-1 optimizes adaptive immune response, creating a comprehensive defense strategy.

Benefits

• Multi-layered immune defense
• Antimicrobial protection
• Immune system optimization
• Chronic infection support

Dosing protocol

Subcutaneous injection 2-3 times per week as directed.

Contraindications

• Severe autoimmune disease
• Organ transplant
• Pregnancy

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.